GlassScriptPhysician profile
Elliott Bettman
NPI 1144325804
$3,020.85
in general payments reported to CMS, 2019-2025
17 companies · $15.70 in 2025
The $15.70 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $296 · 2021: $380 · 2022: $488 · 2023: $415 · 2024: $426 · 2025: $15.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $967.37 | 2019-2024 | Farxiga, Airsupra |
| Abbvie INC. | $429.23 | 2019-2023 | Mavyret, Vraylar |
| Glaxosmithkline, LLC. | $304.60 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Amgen INC. | $228.09 | 2019-2021 | |
| Pfizer INC. | $213.29 | 2019-2020 | |
| Allergan, INC. | $174.97 | 2019-2020 | |
| Lilly USA, LLC | $139.78 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $129.43 | 2019-2025 | Rexulti |
| Sunovion Pharmaceuticals INC. | $127.68 | 2019-2021 | |
| Indivior INC. | $114.13 | 2019-2023 | Sublocade |
| Hikma Pharmaceuticals USA | $34.19 | 2022 | |
| Sanofi-Aventis U.S. LLC | $33.10 | 2019 | |
| Orexo US, INC. | $29.83 | 2019 | |
| Amarin Pharma, INC. | $27.68 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.73 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $23.63 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliott Bettman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.